Eribulin

Eribulin
Product Description

Breast cancer liposarcoma
Status: under development

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

  • On CPHI since:
    2021
  • Certificates:
    2
Company types
Academic/Research
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    253128-41-5

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

  • On CPHI since:
    2021
  • Certificates:
    2
Company types
Academic/Research
Manufacturer/Innovator

More Products from ZENJI PHARMACEUTICALS (SU ZHOU) LTD. (38)